Key findings
Common cancer screening tests, except for sigmoidoscopy, fail to produce gains in life expectancy, according to a meta-analysis of 2.1 million individuals from 18 randomised clinical trials. The findings by an international team, including Norwegian, Swedish, and Polish researchers, appear in JAMA Internal Medicine .
Background and/or implications ...
